These findings fit with observations reported in models of EAE, asthma and collagen-induced arthritis showing enhanced CD4+ T cell activation, proliferation and cytokine production after administration of agonist anti-GITR antibodies [23], [24]. Here, TNFRSF18 is linked to asthma.